Noah G. Levy, Director at MERRIMACK PHARMACEUTICALS INC (MACK), bought 16,085 shares at $4.92 ($81K) on 2022-06-10, disclosed to the SEC on 2022-06-14.
Open-market purchase of $81k MACK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.92 | 2,733 | $13K | 16.5% |
| 2 | $4.92 | 3,653 | $18K | 22.1% |
| 3 | $5.15 | 4,151 | $21K | 26.3% |
| 4 | $5.15 | 5,548 | $29K | 35.1% |
| Total | $5.06 avg | 16,085 | $81K | 100% |
| Filing → |
| MACK | BUY | 2022-07-11 | $15K | — | Filing → |
| MACK | BUY | 2022-07-05 | $9K | — | Filing → |
| MACK | BUY | 2022-01-28 | $353K | — | Filing → |